Keywords :
Carcinoma in Situ/pathology; Carcinoma, Squamous Cell/immunology/pathology; Cell Separation; Cells, Cultured; Cervical Intraepithelial Neoplasia/immunology; Epithelial Cells/immunology; Female; Humans; Immunohistochemistry; Immunophenotyping; Interleukin-2/pharmacology; Lymphocyte Activation; Precancerous Conditions/immunology; Stromal Cells/immunology/pathology; T-Lymphocyte Subsets/immunology/pathology; Uterine Cervical Neoplasms/immunology
Abstract :
[en] In this study, we have developed a simple and efficient technique for the isolation of viable lymphocytes from the epithelium and stroma of small pre-neoplastic squamous intraepithelial lesions (SIL) of the uterine cervix. Following the separation of the epithelium from the stroma using dispase II, both biopsy fragments were used to generate T lymphocytes. The stroma-derived lymphocytes were obtained by collecting and culturing the cells migrating out of the biopsy in the presence of IL2 (50 U/ml). An average of 0.7 x 10(6) and 1.4 x 10(6) lymphocytes could be obtained after 20 and 30 days of culture, respectively. For the expansion of lymphocytes derived from the pre-neoplastic epithelium (SIL) it was necessary to use a combination of irradiated peripheral blood mononuclear cells (PBMC) as a feeder layer with PHA (0.1%), in addition to IL2 (50 U/ml). Interestingly, these lymphocytes could be obtained using either allogeneic or syngeneic PBMCs. With this protocol, we were able to generate up to 100 x 10(6) lymphocytes from the epithelium, the majority of which were T lymphocytes.
Scopus citations®
without self-citations
3